Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

CUBN as a novel locus for end-stage renal disease: insights from renal transplantation.

Reznichenko A, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.

PLoS One. 2012;7(5):e36512. doi: 10.1371/journal.pone.0036512. Epub 2012 May 4.

2.

UMOD as a susceptibility gene for end-stage renal disease.

Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G; REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.

BMC Med Genet. 2012 Sep 5;13:78. doi: 10.1186/1471-2350-13-78.

3.

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L; members of the Comité de Cancerologie de l'Association Française d'Urologie (CCAFU); Comité de Transplantation de l'Association Française d'Urologie (CTAFU).

BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.

4.

Duration of end-stage renal disease and kidney transplant outcome.

Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.

Nephrol Dial Transplant. 2005 Jan;20(1):167-75. Epub 2004 Nov 16.

PMID:
15546892
5.
6.

Uromodulin in renal transplant recipients: elevated urinary levels and bimodal association with graft failure.

Reznichenko A, van Dijk MC, van der Heide JH, Bakker SJ, Seelen M, Navis G.

Am J Nephrol. 2011;34(5):445-51. doi: 10.1159/000332231. Epub 2011 Sep 29.

PMID:
21968132
7.

Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?

Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, De Zeeuw D, De Jong PE.

J Am Soc Nephrol. 1998 Nov;9(11):2075-81.

8.

The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys.

Hayes JM, Steinmuller DR, Streem SB, Novick AC.

Transplantation. 1991 Nov;52(5):813-7.

PMID:
1949166
9.

Renal allograft survival in patients with oxalosis.

Cibrik DM, Kaplan B, Arndorfer JA, Meier-Kriesche HU.

Transplantation. 2002 Sep 15;74(5):707-10.

PMID:
12352890
10.

Toll-Like Receptor Family Polymorphisms Are Associated with Primary Renal Diseases but Not with Renal Outcomes Following Kidney Transplantation.

Dessing MC, Kers J, Damman J, Leuvenink HG, van Goor H, Hillebrands JL, Hepkema BG, Snieder H, van den Born J, de Borst MH, Bakker SJ, Navis GJ, Ploeg RJ, Florquin S, Seelen M, Leemans JC.

PLoS One. 2015 Oct 7;10(10):e0139769. doi: 10.1371/journal.pone.0139769. eCollection 2015.

11.

Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans.

Ma J, Guan M, Bowden DW, Ng MC, Hicks PJ, Lea JP, Ma L, Gao C, Palmer ND, Freedman BI.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):1034-43. doi: 10.2215/CJN.12971215. Epub 2016 May 19.

12.

The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival.

Goldfarb-Rumyantzev AS, Hurdle JF, Scandling JD, Baird BC, Cheung AK.

Am J Kidney Dis. 2005 Sep;46(3):537-49.

PMID:
16129217
13.

How do living kidney donors develop end-stage renal disease?

Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S.

Am J Transplant. 2009 Nov;9(11):2514-9. doi: 10.1111/j.1600-6143.2009.02795.x. Epub 2009 Aug 14.

14.

DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.

Trabulus S, Guven GS, Altiparmak MR, Batar B, Tun O, Yalin AS, Tunckale A, Guven M.

Mol Biol Rep. 2012 Jun;39(6):6995-7001. doi: 10.1007/s11033-012-1529-8.

PMID:
22302399
15.

[Changing profiles of proteinuria in renal transplantation. Predictive factors for its appearance].

Jiménez del Cerro LA, Franco A, Olivares J.

Nefrologia. 2002;22(4):356-63. Spanish.

16.

Respective predictive role of urinary albumin excretion and nonalbumin proteinuria on graft loss and death in renal transplant recipients.

Halimi JM, Matthias B, Al-Najjar A, Laouad I, Chatelet V, Marlière JF, Nivet H, Lebranchu Y.

Am J Transplant. 2007 Dec;7(12):2775-81. Epub 2007 Oct 19.

17.

The fate of organs refused locally and transplanted elsewhere.

Cadillo-Chávez R, Santiago-Delpín EA, González-Caraballo Z, Morales-Otero L, Saade M, Davis J, Heinrichs D.

Transplant Proc. 2006 Apr;38(3):892-4.

PMID:
16647501
18.

Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.

Chavalitdhamrong D, Gill J, Takemoto S, Madhira BR, Cho YW, Shah T, Bunnapradist S.

Transplantation. 2008 Jun 15;85(11):1573-9. doi: 10.1097/TP.0b013e31817059a1.

PMID:
18551062
19.

Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.

Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM.

Nephrol Dial Transplant. 2002 Jul;17(7):1197-203.

PMID:
12105241
20.

The UNOS Scientific Renal Transplant Registry.

Cecka JM.

Clin Transpl. 1996:1-14.

PMID:
9286555

Supplemental Content

Support Center